| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-05 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | 0.13 | 2e-05 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | 0.13 | 2e-05 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | 0.14 | 2e-05 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.16 | 2e-05 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.13 | 2e-05 |
| mRNA | vorinostat:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.14 | 2e-05 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.13 | 3e-05 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | 0.12 | 5e-05 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | 0.15 | 6e-05 |